- Home
- CDTX vs FLYX Comparison
CDTX vs FLYX Comparison
Compare CDTX & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- FLYX
- Stock Information
- Founded
- CDTX 2012
- FLYX 2015
- Country
- CDTX United States
- FLYX United States
- Employees
- CDTX N/A
- FLYX N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FLYX Blank Checks
- Sector
- CDTX Health Care
- FLYX Finance
- Exchange
- CDTX Nasdaq
- FLYX Nasdaq
- Market Cap
- CDTX 259.0M
- FLYX 264.1M
- IPO Year
- CDTX 2015
- FLYX N/A
- Fundamental
- Price
- CDTX $21.69
- FLYX $2.97
- Analyst Decision
- CDTX Strong Buy
- FLYX
- Analyst Count
- CDTX 8
- FLYX 0
- Target Price
- CDTX $38.00
- FLYX N/A
- AVG Volume (30 Days)
- CDTX 164.0K
- FLYX 8.5K
- Earning Date
- CDTX 05-08-2025
- FLYX 01-01-0001
- Dividend Yield
- CDTX N/A
- FLYX N/A
- EPS Growth
- CDTX N/A
- FLYX N/A
- EPS
- CDTX N/A
- FLYX N/A
- Revenue
- CDTX $1,275,000.00
- FLYX $327,274,000.00
- Revenue This Year
- CDTX N/A
- FLYX $28.47
- Revenue Next Year
- CDTX N/A
- FLYX $22.44
- P/E Ratio
- CDTX N/A
- FLYX N/A
- Revenue Growth
- CDTX N/A
- FLYX 3.78
- 52 Week Low
- CDTX $10.14
- FLYX $1.79
- 52 Week High
- CDTX $28.42
- FLYX $8.39
- Technical
- Relative Strength Index (RSI)
- CDTX 56.70
- FLYX 48.91
- Support Level
- CDTX $19.97
- FLYX $2.67
- Resistance Level
- CDTX $22.80
- FLYX $3.10
- Average True Range (ATR)
- CDTX 1.37
- FLYX 0.19
- MACD
- CDTX 0.29
- FLYX -0.00
- Stochastic Oscillator
- CDTX 74.55
- FLYX 60.50
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.